Skip to main content

Table 3 Changes in clinical outcome measures

From: A randomized clinical control study on the efficacy of three-dimensional upper limb robotic exoskeleton training in chronic stroke

Outcome measure

Group

Baseline

Changes after therapy

p of change within groups

p between groups at baseline

p of changes between groups

p ANOVA main effect

FM

CTR

26.7 ± 16.3

8.9 ± 17.6

< 0.01**

0.86

0.46

< 0.01**

ROB

25.6 ± 12.3

11.1 ± 13.9

< 0.01**

FM (proximal)

CTR

19.3 ± 11.0

2.6 ± 10.9

< 0.05*

0.74

< 0.05*

< 0.01**

ROB

18.0 ± 6.6

6.9 ± 7.8

< 0.01**

FM (distal)

CTR

7.5 ± 6.6

6.3 ± 8.0

< 0.01**

0.94

0.28

< 0.01**

ROB

7.6 ± 6.2

4.2 ± 6.7

< 0.01**

Ashworth

CTR

20.6 ± 9.8

1.4 ± 11.5

0.66

0.44

0.99

0.50

ROB

17.1 ± 11.5

1.5 ± 13.7

0.61

BAT timing

CTR

14.1 ± 3.7

− 2.2 ± 3.4

< 0.01**

0.05

< 0.01**

< 0.01**

ROB

17.3 ± 3.6

− 4.8 ± 3.7

< 0.01**

BAT quality

CTR

2.5 ± 1.1

0.6 ± 1.0

< 0.01**

0.35

0.20

< 0.01**

ROB

2.1 ± 0.8

0.9 ± 0.8

< 0.01**

BAT timing pinch tasks

CTR

15.0 ± 4.5

− 2.2 ± 4.3

< 0.01**

0.05

< 0.05*

< 0.01**

ROB

18.8 ± 4.5

− 5.6 ± 4.4

< 0.01**

BAT quality pinch task

CTR

2.6 ± 1.0

0.5 ± 1.0

< 0.01**

0.18

0.06

< 0.01**

ROB

2.0 ± 0.7

0.9 ± 0.8

< 0.01**

BAT timing power task

CTR

13.4 ± 3.3

− 2.5 ± 3.1

< 0.01**

0.12

< 0.05*

< 0.01**

ROB

15.9 ± 3.7

− 4.1 ± 3.7

< 0.01**

BAT quality power task

CTR

2.6 ± 1.0

0.4 ± 0.9

< 0.01**

0.25

0.08

< 0.01**

ROB

2.2 ± 0.8

0.9 ± 0.8

< 0.01**

  1. Values for baseline and change are given as means ± standard deviations